Second round results from the Manchester 'Lung Health Check' community-based targeted lung cancer screening pilot
AffiliationManchester Thoracic Oncology Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK
MetadataShow full item record
AbstractWe report results from the second annual screening round (T1) of Manchester's 'Lung Health Check' pilot of community-based lung cancer screening in deprived areas (undertaken June to August 2017). Screening adherence was 90% (n=1194/1323): 92% of CT scans were classified negative, 6% indeterminate and 2.5% positive; there were no interval cancers. Lung cancer incidence was 1.6% (n=19), 79% stage I, treatments included surgery (42%, n=9), stereotactic ablative radiotherapy (26%, n=5) and radical radiotherapy (5%, n=1). False-positive rate was 34.5% (n=10/29), representing 0.8% of T1 participants (n=10/1194). Targeted community-based lung cancer screening promotes high screening adherence and detects high rates of early stage lung cancer.
CitationCrosbie PA, Balata H, Evison M, Atack M, Bayliss-Brideaux V, Colligan D, et al. Second round results from the Manchester 'Lung Health Check' community-based targeted lung cancer screening pilot. Thorax. 2018 Nov 12.